SCHEMBL6023328

SCHEMBL6023328

CCCCCCCCCOc1cc(C(=O)O)cc(OCCCCCCCCC)c1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.66
ALDH1A1 P00352 1/20 0.57
HPGD P15428 1/20 0.57
TP53 P04637 1/20 0.57
TSHR P16473 1/20 0.57
PTPN11 Q06124 2/20 0.56
PLA2G4B P0C869 1/20 0.55
SMPD1 P17405 1/20 0.54
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA3 P07451 1/20 0.53
PKM P14618 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA5A P35218 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
CA5B Q9Y2D0 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11137601 0.94 PLA2G2A (0.62) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL1200906 0.87 PLA2G2A (0.66) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL1200763 0.87 PLA2G2A (0.66) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL318045 0.87 PLA2G2A (0.66) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL1200970 0.87 PLA2G2A (0.66) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL1201538 0.87 PLA2G2A (0.66) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL1201453 0.87 PLA2G2A (0.66) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL1108059 0.87 PLA2G2A (0.66) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL1108057 0.87 PLA2G2A (0.66) PLA2G2AALDH1A1HPGDTP53TSHR
SCHEMBL14620895 0.87 PTGS2 (0.59) PLA2G2AALDH1A1HPGDTP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 PLA2G2A 3288/4885ALDH1A1 804/4885HPGD 72/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.